2001
Can HIV-1-Contaminated Syringes Be Disinfected?
Abdala N, Gleghorn A, Carney J, Heimer R. Can HIV-1-Contaminated Syringes Be Disinfected? JAIDS Journal Of Acquired Immune Deficiency Syndromes 2001, 28: 487-494. DOI: 10.1097/00126334-200112150-00013.Peer-Reviewed Original ResearchCan HIV-1-Contaminated Syringes Be Disinfected?: Implications for Transmission Among Injection Drug Users.
Abdala N, Gleghorn A, Carney J, Heimer R. Can HIV-1-Contaminated Syringes Be Disinfected?: Implications for Transmission Among Injection Drug Users. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2001, 28: 487. PMID: 11744839, DOI: 10.1097/00042560-200112150-00013.Peer-Reviewed Original ResearchConceptsInjection drug usersHIV-1Undiluted bleachDrug usersHIV-1 recoveryViable HIV-1HIV-1 transmissionHarm reduction interventionsEffectiveness of bleachNeedle exchangeReduction interventionsMicroculture assaySingle rinseSterile syringeSyringesInjection behaviorEducational programsMinimal contact time
1993
Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut
Heimer R, Kaplan E, Khoshnood K, Jariwala B, Cadman E. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut. The American Journal Of Medicine 1993, 95: 214-220. PMID: 8356986, DOI: 10.1016/0002-9343(93)90263-o.Peer-Reviewed Original ResearchConceptsHIV-1 proviral DNANeedle exchange programsProviral DNANew Haven's needle exchange programNeedle exchangeHIV-1 prevalenceIntravenous drug usersNeedle exchange clientsDrug treatment programsPercentage of syringesDrug use habitsSyringe trackingDNA prevalenceNew HavenPolymerase chain reactionDrug treatmentDrug usersTreatment programPrevalenceChain reactionExchange programsSyringesMonthsProgram participantsFunded evaluation